Becton Dickinson (BDX) Depreciation & Amortization (CF) (2009 - 2026)
Becton Dickinson's (BDX) quarterly Depreciation & Amortization (CF) came in at $563.0 million in Q1 2026, down 0.71% year-on-year from $567.0 million in Q1 2025, and down 8.31% on a QoQ basis from $614.0 million in Q4 2025.
Becton Dickinson (BDX) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Depreciation & Amortization (CF) data on file, last reported at $563.0 million in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 0.71% year-over-year to $563.0 million in Q1 2026; TTM through Mar 2026 was $2.5 billion, a 7.73% increase from a year earlier, with the FY2025 full-year figure at $2.5 billion, up 7.7% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $563.0 million, down from $614.0 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for BDX reached as high as $702.0 million in Q2 2025 and fell as low as $548.0 million in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $584.6 million across 5 years, with a median of $571.0 million in 2023.
- Across the five-year window, Depreciation & Amortization (CF) decreased 1.79% in 2022 and rose 23.59% in 2025, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $567.0 million in 2022, then slipped by 1.06% to $561.0 million in 2023, then rose by 8.2% to $607.0 million in 2024, then rose by 1.15% to $614.0 million in 2025, then fell by 8.31% to $563.0 million in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $563.0 million in Q1 2026, $614.0 million in Q4 2025, and $629.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 563.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 254.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 58.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 45.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 135.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 56.55 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 237.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 563.00 Mn |
| Mar 31, 2026 | 563.00 Mn |
| Dec 31, 2025 | 614.00 Mn |
| Dec 31, 2025 | 614.00 Mn |
| Sep 30, 2025 | 629.00 Mn |
| Sep 30, 2025 | 629.00 Mn |
| Jun 30, 2025 | 702.00 Mn |
| Jun 30, 2025 | 702.00 Mn |
| Mar 31, 2025 | 567.00 Mn |
| Mar 31, 2025 | 567.00 Mn |
| Dec 31, 2024 | 607.00 Mn |
| Dec 31, 2024 | 607.00 Mn |
| Sep 30, 2024 | 586.00 Mn |
| Sep 30, 2024 | 586.00 Mn |
| Jun 30, 2024 | 568.00 Mn |
| Jun 30, 2024 | 568.00 Mn |
| Mar 31, 2024 | 571.00 Mn |
| Mar 31, 2024 | 571.00 Mn |
| Dec 31, 2023 | 561.00 Mn |
| Dec 31, 2023 | 561.00 Mn |